Teligent EPS - Earnings per Share 2010-2021 | TLGT
Teligent eps - earnings per share from 2010 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Teligent Annual EPS |
| 2020 |
$-14.67 |
| 2019 |
$-4.67 |
| 2018 |
$-6.80 |
| 2017 |
$-2.80 |
| 2016 |
$-2.30 |
| 2015 |
$-0.70 |
| 2014 |
$0.90 |
| 2013 |
$-0.30 |
| 2012 |
$-1.00 |
| 2011 |
$-0.80 |
| 2010 |
$-2.00 |
| 2009 |
$-4.60 |
| Teligent Quarterly EPS |
| 2021-06-30 |
$-0.14 |
| 2021-03-31 |
$0.03 |
| 2020-12-31 |
$-7.05 |
| 2020-09-30 |
$-0.08 |
| 2020-06-30 |
$-2.56 |
| 2020-03-31 |
$-4.98 |
| 2019-12-31 |
$-1.01 |
| 2019-09-30 |
$-1.32 |
| 2019-06-30 |
$-0.74 |
| 2019-03-31 |
$-1.60 |
| 2018-12-31 |
$-2.70 |
| 2018-09-30 |
$-0.70 |
| 2018-06-30 |
$-2.50 |
| 2018-03-31 |
$-0.90 |
| 2017-12-31 |
$-1.10 |
| 2017-09-30 |
$-1.70 |
| 2017-06-30 |
$-0.20 |
| 2017-03-31 |
$0.20 |
| 2016-12-31 |
$-1.10 |
| 2016-09-30 |
$-0.50 |
| 2016-06-30 |
$-0.50 |
| 2016-03-31 |
$-0.20 |
| 2015-12-31 |
$0.00 |
| 2015-09-30 |
$-0.50 |
| 2015-06-30 |
$-0.30 |
| 2015-03-31 |
$0.10 |
| 2014-12-31 |
$1.00 |
| 2014-09-30 |
$0.00 |
| 2014-06-30 |
$-0.10 |
| 2014-03-31 |
$0.00 |
| 2013-12-31 |
$-0.08 |
| 2013-09-30 |
$-0.02 |
| 2013-06-30 |
$-0.10 |
| 2013-03-31 |
$-0.10 |
| 2012-12-31 |
$-0.30 |
| 2012-09-30 |
$-0.40 |
| 2012-06-30 |
$-0.10 |
| 2012-03-31 |
$-0.20 |
| 2011-12-31 |
$-0.20 |
| 2011-09-30 |
$-0.10 |
| 2011-06-30 |
$-0.20 |
| 2011-03-31 |
$-0.30 |
| 2010-12-31 |
$0.10 |
| 2010-09-30 |
$-0.80 |
| 2010-06-30 |
$-0.60 |
| 2010-03-31 |
$-0.70 |
| 2009-12-31 |
$-0.50 |
| 2009-09-30 |
$-0.50 |
| 2009-06-30 |
$-2.30 |
| 2009-03-31 |
$-1.30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
